H.I.G. Capital has agreed to acquire the spine business of ZimVie (Nasdaq: ZIMV) for $375 million, according to a news release.
H.I.G. will acquire Zimvie’s spine, motion preservation and EBI bone healing technologies.
ZimVie was formed less than two years ago when Zimmer Biomet spun out its dental and spine segments. Following the sale, ZimVie
Although investment in the orthopedic sector is not new, private equity investment interest in this specialty area continues to grow. In fact, orthopedics has become one of the leading sectors for private equity investing, just behind cardiology.
In this episode of The Corner Series, McGuireWoods partner Geoff Cockrell speaks with Scott Davis, managing
Windjammer Capital has announced it has acquired Bio X Cell (BXC).
BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications.
Windjammer, based in Newport Beach, Calif., and Waltham, Mass., is a private equity firm focused
The U.S. Department of Health and Human Services Office of Inspector General recently issued Advisory Opinion 23-08, continuing its long-held position that the provision of value-added items and services implicates fraud and abuse laws, including the Federal Anti-Kickback Statute and the Beneficiary Inducement Civil Monetary Penalty law.
Read on to learn how manufacturers, distributors, and
Accel-KKR has announced it has invested in Ntracts.
Ntracts, founded in 2007 and based in Chattanooga, Tenn., is a provider of contract lifecycle management solutions for healthcare organizations.
Accel-KKR, based in Menlo Park, Calif., is a technology-focused investment firm. The firm pursues middle-market companies and provides a broad range of capital solutions, including
NewSpring has announced it has closed its latest fund with more than $180 million in commitments.
The fund, NewSpring Health Capital IV (NSH IV), was oversubscribed.
NSH IV made six investments prior to the final close: AeroSafe Global, BetterNight, Healthworks, Patheous Health, Prosperity Behavior Health and Verisma.
NewSpring, based in Radnor, Pa., is a
Pharos Capital Group has announced it has acquired a majority stake in RhythMedix.
RhythMedix, founded in 2013 and based in Mt. Laurel, N.J., is a manufacturer and provider of remote cardiac monitoring systems and related services.
Pharos, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle
RoundTable Healthcare Partners has announced it has sold TIDI Products to TJC.
TIDI, founded in 1969 and based in Neenah, Wisconsin, is a manufacturer, marketer and distributor of a portfolio of medical products. The company is best known for its falls prevention and patient safety products.
RoundTable, based in Lake Forest, Ill., is
On Dec. 20, 2023, the Federal Trade Commission announced its intent to file a notice of proposed rulemaking related to the Children’s Online Privacy Protection Rule — the first proposed changes to the rule in 10 years.
What are some of the key proposed changes?
Last week, Merck & Co. filed documents with the Supreme Court of New Jersey indicating that it reached a settlement with its “all risk” property insurers in a long-running coverage dispute involving over $1.4 billion in losses stemming from a 2017 NotPetya cyberattack that impacted tens of thousands of Merck computers. The coverage litigation, Merck & Co. v. ACE American Insurance Co., focused on the key question of whether the policies’ “hostile/warlike” exclusion applied to the NotPetya attack, which some intelligence agencies have attributed to Russian government attempts to destabilize Ukraine. The settlement was announced just a few days before the New Jersey Supreme Court was set to hear oral arguments during an appeal of the New Jersey state appeals court’s affirmance of a 2021 trial court ruling in Merck’s favor. Merck’s insurers had argued that Merck’s losses were barred by a war exclusion, but the New Jersey trial court found that the exclusion did not apply to malware and cyberattacks and instead was intended to apply only to physical acts of warfare between the armed forces of two or more countries. The terms and the amount of the settlement have not yet been disclosed.